Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow Reinvestment Rate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow Reinvestment Rate of 0.48x as of September 2025, reinvesting CN¥56.87 Million (capex CN¥56.87 Million ) from operating cash flow of CN¥117.38 Million. Explore how much does Zhangzhou Pientzehuang Pharmaceutical Co reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 24 annual periods. Also explore 600436 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market value of Zhangzhou Pientzehuang Pharmaceutical Co.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.00x | CN¥539.00 Million | CN¥77.03 Million | CN¥339.80 Million | ▲ +617.2% |
| 2024 | 0.98x | CN¥1.28 Billion | CN¥1.31 Billion | CN¥1.07 Billion | ▼ -3.0% |
| 2023 | 1.01x | CN¥2.22 Billion | CN¥2.21 Billion | CN¥141.87 Million | ▲ +8.9% |
| 2022 | 0.92x | CN¥6.35 Billion | CN¥6.87 Billion | CN¥175.37 Million | ▲ +81.2% |
| 2021 | 0.51x | CN¥235.49 Million | CN¥462.27 Million | CN¥92.17 Million | ▲ +72.2% |
| 2020 | 0.30x | CN¥434.05 Million | CN¥1.47 Billion | CN¥419.01 Million | ▲ +139.9% |
| 2018 | 0.12x | CN¥75.52 Million | CN¥612.31 Million | CN¥74.24 Million | ▼ -37.6% |
| 2017 | 0.20x | CN¥133.69 Million | CN¥676.93 Million | CN¥51.87 Million | ▼ -78.9% |
| 2016 | 0.94x | CN¥369.26 Million | CN¥394.54 Million | CN¥90.97 Million | ▲ +140.9% |
| 2015 | 0.39x | CN¥118.68 Million | CN¥305.51 Million | CN¥78.86 Million | ▲ +297.3% |
| 2014 | 0.10x | CN¥25.87 Million | CN¥264.50 Million | CN¥25.87 Million | ▼ -81.7% |
| 2013 | 0.53x | CN¥146.54 Million | CN¥274.34 Million | CN¥146.54 Million | ▼ -44.1% |
| 2012 | 0.96x | CN¥155.22 Million | CN¥162.40 Million | CN¥155.22 Million | ▲ +526.1% |
| 2011 | 0.15x | CN¥35.56 Million | CN¥232.95 Million | CN¥35.56 Million | ▼ -19.4% |
| 2010 | 0.19x | CN¥38.90 Million | CN¥205.41 Million | CN¥38.90 Million | ▼ -17.3% |
| 2009 | 0.23x | CN¥29.67 Million | CN¥129.52 Million | CN¥29.67 Million | ▼ -95.1% |
| 2008 | 4.65x | CN¥58.50 Million | CN¥12.57 Million | CN¥58.50 Million | ▲ +162.4% |
| 2007 | 1.77x | CN¥106.47 Million | CN¥60.04 Million | CN¥106.47 Million | ▲ +932.2% |
| 2006 | 0.17x | CN¥8.71 Million | CN¥50.70 Million | CN¥8.71 Million | ▼ -65.6% |
| 2005 | 0.50x | CN¥34.54 Million | CN¥69.06 Million | CN¥34.54 Million | ▲ +358.9% |
| 2004 | 0.11x | CN¥10.75 Million | CN¥98.67 Million | CN¥10.75 Million | ▼ -77.3% |
| 2003 | 0.48x | CN¥15.56 Million | CN¥32.36 Million | CN¥15.56 Million | ▲ +419.2% |
| 2002 | 0.09x | CN¥9.77 Million | CN¥105.45 Million | CN¥9.77 Million | ▼ -47.6% |
| 2001 | 0.18x | CN¥11.64 Million | CN¥65.84 Million | CN¥11.64 Million | — |